CVS Health Corp. (CVS) Stock: Price, Forecast & Analyst Target
CVS Health Corp. (CVS) — MoonshotScore 81/100 (Exceptional band), calculated Nov 18, 2026. Price $80.06 (-1.59%), as of the Nov 19, 2026 trading session; market cap $102B. Expected results Feb 9, 2027.
Educational signal · not a buy or sell recommendation · How to read this
CVS Health Corp. · CVS · NYSE · Healthcare · Medical - Healthcare Plans
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services.
Price as of Nov 19, 2026
Key Statistics
MoonshotScore v2 · CVS Health (CVS)
ExceptionalWhy this rating? Method, drivers & history
Bands for the MoonshotScore: Exceptional 80-100 · Strong 65-79 · Fair 45-64 · Weak below 45.
- Business Quality — Is this a genuinely good business?
- Financial Safety — Could this blow up on me?
- Valuation — Am I paying a fair price?
- Growth Durability — Is the growth real and likely to last?
- Momentum — Is the market already moving on this?
High quality and elite growth, at a dirt-cheap price, but a strained balance sheet; the market is already moving on it. Business Quality: Solid; Financial Safety: Strained; Valuation: Cheap; Growth Durability: Compounding; Momentum: Rising.
- quarterly revenue $108.40B (Q3 FY2026, quarter ended Sep 2026)
- EPS beat 8 of the last 8 reports
- expected results Feb 9, 2027
Helping: business quality, an attractive price, durable growth, positive momentum
What has the MoonshotScore done over time?
| Recorded | Score | Band |
|---|---|---|
| 75 | Strong | |
| 75 | Strong | |
| 75 | Strong | |
| 75 | Strong | |
| 81 | Exceptional | |
| 81 | Exceptional |
Daily score refresh is delayed. This is the last recorded calculation.
Calculation uses the most recent completed US trading session. Live price changes do not update the score immediately.
Computed · How the MoonshotScore is computed →
Price & valuation
| Measure | Value | As of |
|---|---|---|
| Latest provided price | $80.06 | |
| Change on the day | -1.59% | |
| 52-week range | $69.51–$110.68 | |
| Market capitalisation | $102B | — |
| Price / earnings (trailing) | 9.91 | |
| Shares traded on the day | 12.47M | |
| Beta (volatility vs the S&P 500) | 0.58 |
Price & events
Triangles mark reported quarters on the line: pointing up is above the recorded estimate, down is below, a diamond means no estimate on file. Numbers key to the dated list. Point at or tab to any week for its close.
Events behind the price
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
- · Earnings results · above the recorded estimate
Results dates follow the earnings feed; call dates follow the transcript provider. Nearby dates do not establish that an event caused a price move.
Upcoming events
How to read these dates
Estimated dates can change.
Other perspectives
Council score for CVS Health (CVS): perspectives
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
5-Factor Breakdown
Legends Council
6 lenses, 0 current
AI simulations built from the named investors' published principles. Not affiliated with, endorsed by, or the opinion of these individuals. How these lenses are built
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
Munger's Mindset
Balance Sheet & Valuation · historical
Read on: Nov 18, 2026 · older than the 27 hours refresh window; not a current reading
How to read these bars and different assessments
Council is a separate blend of available disciplines; MoonshotScore above remains the five-pillar research rating.
Bars show each model's ordered assessment on its own scale, not a probability or a comparable investment return. The adjacent words give the assessment; more filled segments indicate a stronger model reading.
On Nov 18, 2026, the Munger lens read the price at that time as undervalued against its own estimate of value.
Readings on this page are from Nov 20, 2026, except a card that shows its own read date.
What is CVS Health (CVS), and what does it report?
Short answer
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. CVS Health Corp. (CVS) is listed on NYSE. Healthcare / Medical Healthcare Plans SEC filing business address: ONE CVS DR., Woonsocket, RI, 02895. It employs 259,500 people and is led by J. David Joyner. In Q3 FY2026 it reported revenue of $108.40B and net income of $2.17B. The market values it at $102B.
What do the latest results show for CVS Health (CVS)?
Short answer · as of
The most recent reported quarter, Q3 FY2026, carried revenue of $108.40B. Against analyst estimates the company has EPS beat 8 of the last 8 reports.
Where is operating spending going?
Revenue alongside research and development, selling, general and administrative expenses, and the FMP standardized operating result.
| Period end | Revenue | R&D | SG&A | FMP standardized operating result |
|---|---|---|---|---|
| Sep 30, 2026 | Not available | Not available | Not available | Not available |
| Jun 30, 2026 | Not available | Not available | Not available | Not available |
| Mar 31, 2026 | Not available | Not available | Not available | Not available |
| Dec 31, 2025 | Not available | Not available | Not available | Not available |
How to read these figures
Amounts are in US dollars. The operating result is Financial Modeling Prep’s standardized figure, so it can differ from the operating line in the company’s filing. It is not net income or cash flow.
Did results meet expectations?
Reported earnings and revenue alongside the estimates recorded by the provider.
- Latest report · revenue
- $108.40B Nov 4, 2026
- Latest report · revenue estimate
- $104.72B Nov 4, 2026
- Latest report · revenue vs estimate
- Above estimate Nov 4, 2026
- Latest report · EPS vs estimate
- Above estimate Nov 4, 2026
| Report date | Revenue · reported | Revenue · estimate | EPS · reported | EPS · estimate |
|---|---|---|---|---|
| Nov 4, 2026 | $108.40B | $104.72B | $2.0900 | $1.6500 |
| Aug 5, 2026 | $106.10B | $100.03B | $2.5800 | $1.8500 |
| May 6, 2026 | $100.43B | $94.99B | $2.5700 | $2.1800 |
| Feb 10, 2026 | $105.69B | $103.70B | $1.0900 | $1.0000 |
How to read these figures
Dates are when results were reported, not quarter ends. Amounts are in US dollars; EPS is per share. The source does not say whether EPS is basic, diluted or adjusted, so it can differ from the EPS in the income statement.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q3 FY2026 | $108.40B | $2.17B | $1.68 (diluted) |
| Q2 FY2026 | $106.10B | $3.00B | $2.33 (diluted) |
| Q1 FY2026 | $100.43B | $2.94B | $2.30 (diluted) |
| Q4 FY2025 | $105.69B | $2.94B | $2.30 (diluted) |
What are the financial strengths and risks for CVS Health (CVS)?
Short answer
Cash and short-term investments were $0.00 at the Sep 30, 2026 balance-sheet date. This figure does not establish a cash runway. The MoonshotScore pillars rate business quality, an attractive price, durable growth, positive momentum as strengths. The distress and quality screens read Altman Z 2.50 · Piotroski F 8. Trailing ratios: ROE 14.4% · ROA 3.1% · current ratio 0.85.
What should you watch next at CVS Health (CVS)?
Short answer · as of
The next earnings report is expected on Feb 9, 2027. Current published price targets run low $103.00 · high $123.00 · consensus $110.56 · median $110.50 against a quoted price of $80.06 (as of Nov 19, 2026).
How does CVS Health compare with its peers?
Short answer
CVS Health's score ranks tied for 7th of 13 in the bounded comparison shown, against 12 same-model peers. These are company scores, not expected investment returns. The set lists named competitors first, then companies in the same data-provider industry classification closest in market value; that classification is the provider's, not our judgment of business similarity.
| Company | Price | Market value | Score |
|---|---|---|---|
| $27.57 Nov 18, 2026 | $8.57B | 97 5-pillar Nov 18, 2026 | |
| $4.17 Nov 18, 2026 | $2.23B | 94 5-pillar Nov 18, 2026 | |
| $65.62 Nov 19, 2026 | $32.5B | 91 5-pillar Nov 18, 2026 | |
| $536.45 Nov 18, 2026 | $136B | 90 5-pillar Nov 18, 2026 | |
| $400.84 Nov 18, 2026 | $86.6B | 88 5-pillar Nov 18, 2026 | |
| $59.56 Nov 18, 2026 | $122B | 85 5-pillar Nov 18, 2026 | |
| CVS Health (CVS) — this page | $80.06 | $102B | 81 |
| $100.72 Nov 18, 2026 | $129B | 81 5-pillar Nov 18, 2026 | |
| $385.78 Nov 18, 2026 | $46.3B | 79 5-pillar Nov 18, 2026 | |
| $273.09 Nov 19, 2026 | $72.0B | 78 5-pillar Nov 18, 2026 | |
| $48.58 Nov 18, 2026 | $97.4B | 77 5-pillar Nov 18, 2026 | |
| $476.35 Nov 18, 2026 | $99.5B | 77 5-pillar Nov 18, 2026 | |
| $349.91 Nov 18, 2026 | $314B | 76 5-pillar Nov 18, 2026 |
Only 5-pillar scores are ranked together. Other models are not directly comparable. Price and score dates are shown separately; market-value dates are unavailable.
The records behind this page
Analyst targets & estimates
What analysts have on file
- Price target, low to high
- $103.00 – $123.00
- Consensus target
- $110.56
- Median target
- $110.50
Consensus record · Captured .
Measured against a quoted price of $80.06 (as of Nov 19, 2026).
Insider activity
Form 4 records via FMP · Of the newest 100 records, those within the last 180 days, newest dated Nov 6, 2026
- Transactions
- 4
- Identified insiders
- 4
- Purchases
- 1
- Sales
- 0
- Other transactions
- 3
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Who holds the shares?
Institutional ownership reported through 13F filings.
Tracked investors
Which of the 16 named investors we follow held CVS in their latest 13F filing, and what they did against the filing before it.
| Investor | Manager | 13F quarter | Portfolio weight | Value | Last quarter |
|---|---|---|---|---|---|
| Bridgewater Associates | Founded by Ray Dalio | Q3 2026 | 0.14% | $32.40M | Trimmed −14.2% shares |
| Viking Global | Andreas Halvorsen | Q3 2026 | 0% | $0 | Sold out (was $378.97M) |
How to read these figures
These filings arrive after the quarter ends. Names appear as the provider lists them, not as a verified ranking, and without filing dates. Related managers can appear separately, so their shares are not added together. Tracked investors: each fund's own latest 13F, so funds that have not filed the newest quarter yet show their previous one; weight is the share of the fund's reported 13F value.
Common Questions About CVS (Healthcare)
These answers are editorial: 1 of these 8 answers is drawn from the CVS research dossier (written May 10, 2026 by gemini-2.0-flash); the other 7 are question templates that restate figures shown above. Figures in this section are not part of the source register.
What does the MoonshotScore mean for CVS?
CVS carries the MoonshotScore stated above — the Exceptional band. This is an educational research signal, not a buy or sell recommendation. The number comes from the five-pillar engine (business quality, financial safety, valuation, growth durability, momentum), re-ranked daily against sector peers.
Is CVS a good stock to buy?
Stock Expert AI does not rate CVS buy, sell or hold. CVS Health Corp. carries a MoonshotScore, in the Exceptional band, a research rating against its peers rather than a forecast. Whether it fits is your call: check what it sells, whether it earns and what the price assumes. This is educational content, not investment advice.
What is the CVS stock price today?
The last price recorded for CVS Health Corp. (CVS), with its trading session and source, is listed under Price & valuation on this page. It is a provider snapshot, not a live exchange feed, so check a brokerage quote before you trade.
What is the CVS price target?
The analyst consensus price target for CVS Health Corp. (CVS), with its range and the date it was captured from FMP, is listed under Analyst targets & estimates on this page. Targets are analyst opinions and change often; they are not a Stock Expert AI forecast.
What does CVS Health Corporation do?
CVS Health Corporation operates as a diversified healthcare company, providing a wide range of services through its three main segments: Health Care Benefits, Pharmacy Services, and Retail/LTC.
What are the key factors to evaluate for CVS?
CVS Health Corp. (CVS) holds a MoonshotScore in the high range. To weigh it, compare the trailing P/E under Price & valuation with the analyst view under Analyst targets & estimates on this page. Not financial advice.
How frequently does CVS data refresh on this page?
CVS's price is the last quote we recorded, from the Nov 19, 2026 trading session. Pages are served from a cache, so the copy you are reading can lag that quote. The quote is a provider snapshot, not an exchange feed. Fundamentals follow quarterly filings. V2 is recalculated from the most recent completed US trading session; the score's own date shows its last successful run.
What has driven CVS's recent stock price performance?
CVS Health Corp. (CVS) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Integrated healthcare model with diverse revenue streams. See the News tab for the latest drivers. Past performance does not predict future results.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated May 10, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources: the source register lists the 49 figures on this page — 1 from SEC filings and earnings calls, 40 from Financial Modeling Prep (FMP), 5 with no recorded source, 2 computed by us, formula shown in the register and 1 from Stock Expert AI's own score and rank. Its rows (value as shown, as-of date, tier and source link) are in the Markdown version of this page.
Publication details and research sources
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
ETFs that hold CVS
Funds in our ETF coverage that list CVS among the top 10 holdings on their fund page, largest weight first. Each weight is the fund's reported holding weight as of the date in its row.
| ETF | Weight | Holdings as of |
|---|---|---|
| IHF ETF | 13.24% | |
| First Trust Nasdaq Retail ETF (FTXD) | 5.68% | |
| Davis Select U.S. Equity ETF (DUSA) | 5.00% | |
| Invesco S&P 500 Value with Momentum ETF (SPVM) | 1.33% | |
| Invesco Global ESG Revenue ETF (ESGF) | 0.88% |